At a busy and highly successful interim meeting of the AMA House of Delegates, an ACR-cosponsored resolution that calls for exceptions to therapy caps was passed and will become AMA policy. Other areas addressed include payment parity for telemedicine and MIPS reform.
Articles by From the College
RheumCode: Creating a Common Rheumatology Language in EHRs
This ACR initiative aims to create a common language to define key data elements for rheumatology and make it easier to compare patient data across EHR systems.
As ARP President, Adam Goode, PT, DPT, PhD, Will Draw on Power of Interdisciplinary Members
The diversity of the ARP’s membership is what originally drew Adam Goode, PT, DPT, PhD, to the organization, enticed him to begin volunteering more than a decade ago and now galvanizes him as he becomes the new ARP president.
New ACR President Carol Langford, MD, MHS, Has Optimistic Outlook for Future of Rheumatology
“At my very first annual meeting of the ACR, I saw how the ACR brought the whole rheumatology community together, and I knew right away that it was an organization that I wanted to be a part of,” Dr. Langford says. In late November, she became the 88th president of the ACR and looks forward to continuing its focus on education, research and building community.
ACR Updates Position Statement on Complementary & Integrative Medicine for Rheumatic Disease
The position refers to relevant ACR clinical guidelines and supports continued research and innovative methods for evaluating these modalities in clinical practice.
Unless Congress Acts, Medicare Reimbursement Will Remain Flat or Drop in 2025
The 2025 Medicare Physician Fee Schedule final rule, released Nov. 1, includes a conversion factor of $32.3465, a 2.83% drop from 2024. In response to advocacy efforts from the ACR and other medical societies, Congress recently introduced the Medicare Patient Access and Practice Stabilization Act of 2024, which would eliminate the 2.83% payment cut and provide an inflationary update for 2025 equal to 50% of the Medicare Economic Index.
Updates from the ACR Insurance Subcommittee
The ACR Insurance Subcommittee (ISC) of the Committee on Rheumatologic Care has been hard at work, advocating to payers on behalf of the ACR and its members. Following is an update on some of the work this group has been doing to help address concerns about reimbursement and administrative burden, while ensuring continued access to…
2024 Election Summary, Outlook for the Lame Duck Session & the New Congress
With a likely Republican majority in the House and Senate and a Republican president, there may be a sense that the party has a mandate to lead initiatives and enact significant policy changes. Any end-of-year legislative package will be narrower than initially expected, but the ACR’s top priority remains addressing cuts to physician reimbursements.
ATAP Board Appointments for 2024-25 Include 2 Distinguished ACR Members
The Alliance for Transparent and Affordable Prescriptions’ board members for the 2024–25 cycle include Marcus Snow, MD, and Howard Blumstein, MD, who both have a strong history of volunteer leadership in the ACR.
After Coalition Meeting, CMS Leadership Agrees to Closer Look at Underwater Biosimilars
The Underwater Biosimilars Coalition shared with the Centers for Medicare & Medicaid Services concerns about problems arising from the average sales price payment methodology and discussed potential options for addressing these challenges.
- 1
- 2
- 3
- …
- 90
- Next Page »